Brief: Oncology Institute Q2 Revenue Rose 22.2% To $61 Mln

Starling Oncology

09/08/2022 22:28

Aug 9 (Reuters) - Oncology Institute Inc  TOI.O :
    * THE ONCOLOGY INSTITUTE REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND REAFFIRMS FULL YEAR 2022 GUIDANCE
    * Q2 REVENUE ROSE 22.2 PERCENT TO $61 MILLION
    * Q2 LOSS PER SHARE $0.06

Source text for Eikon:  ID:nGNX40NnkH 
Further company coverage:  TOI.O 

 ((Reuters.Briefs@thomsonreuters.com;))